Log in to search using one of your social media accounts:

 

Kidney Cancer Renal Pelvis and Ureter
Kidney Cancer: Renal Pelvis and Ureter (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - August 22, 2017 Category: General Medicine Source Type: news

Cogentix Medical buys UK-based Genesis Medical
Cogentix Medical (NSDQ:CGNT) said today it acquired London-based Genesis Medical for an undisclosed amount. Genesis Medical produces, sells and markets urology products in the U.K. and operated as the exclusive regional distributor for Cogentix’s PrimeSight endoscopy systems. Cogentix said it purchased all tangible assets of Genesis, and will pay up to an additional $671,560 (GBP £515,000) based on revenue milestones through March 2019. “The purchase of Genesis Medical is our second business development transaction this month and follows our announcement last week of an Endo-Urology product line laun...
Source: Mass Device - July 26, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Urology Cogentix Medical Source Type: news

Cogentix inks deal with Promepla to launch endo-urology devices in US
Cogentix Medical (NSDQ:CGNT) said today it inked a deal with Monaco-based medical device maker Promepla to launch an endo-urology product line within the US. Minneapolis, Minn.-based Cogentix said the slated-to-launch product line includes a full suite of endourological devices including ureteral access sheaths, gravity irrigation lines and nitinol guide wires. “The launch of our endo-urology product line in the U.S. is one of the first steps in executing our business development strategy. Our primary focus for business development has been to add products that can immediately leverage the relationships our U.S....
Source: Mass Device - July 18, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Urology Cogentix Medical Promepla Source Type: news

Renal Nerves and Blood Pressure
Role of Calcitonin gene-related peptide (CGRP) CGRP is a potent vasodilator so it is not surprising ourCGRP Antibody was used in this study. Cust ódio AH, de Lima MC, Vaccari B, Boer PA, Gontijo JAR (2017)Renal sodium handling and blood pressure changes in gestational protein-restricted offspring: Role of renal nerves and ganglia neurokinin expression. PLoS ONE 12(6): e0179499. https://doi.org/10.1371/journal.pone.0179499Figure. Comparative expression of SP and CGRP in the renal pelvis of 16-week-old rats. The pictures show a normal distribution of these neurokinins in NP (A and D). In LP offspring, no difference wa...
Source: Neuromics - July 5, 2017 Category: Neuroscience Tags: Blood Pressure CGRP antibody sodium channels Source Type: news

Ureteroscopy, Lithotripsy Have Different Risk-benefit Profile for Upper Ureteral Stones Ureteroscopy, Lithotripsy Have Different Risk-benefit Profile for Upper Ureteral Stones
Ureteroscopy and shock-wave lithotripsy have different relative benefits and harms in patients with upper ureteral stones, according to a new systematic review.Reuters Health Information (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - May 11, 2017 Category: Urology & Nephrology Tags: Urology News Source Type: news

Carrying Savanna through her journey with cloacal malformation
When two-year-old Savanna Bluford enters Boston Children’s Colorectal and Pelvic Malformation Center, she quickly gravitates toward the waiting room’s interactive light board. Sporting pigtails, sparkly sneakers and an angelic smile, the playful toddler’s attention quickly turns to her doctor — the Center’s Co-Director Dr. Belinda Dickie. The two light up with smiles and exchange hugs as if old friends — and that, they are. Savanna was born in South Carolina with a rare and complex birth defect affecting the gastrointestinal, urological and reproductive systems. The condition, called cov...
Source: Thrive, Children's Hospital Boston - May 3, 2017 Category: Pediatrics Authors: Maureen McCarthy Tags: Diseases & Conditions Our Patients’ Stories Belinda Dickie cloacal malformation Colorectal and Pelvic Malformation Center Leonel Rodriguez Source Type: news

MassDevice.com +5 | The top 5 medtech stories for April 12, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. GE, Hartford Healthcare ink 7-year value based care partnership GE Healthcare said today it is collaborating with Hartford HealthCare to launch a series of value-based healthcare projects over the next 7 years. The companies sa...
Source: Mass Device - April 12, 2017 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Cook Medical recalls select Bush ureteral illuminating caths
Cook Medical this week released information on a select voluntary recall of its Bush DL and Bush SL ureteral illuminating catheter sets over issues with overheating. The Bloomington, Ind.-based company said it has received an increased number of reports of the proximal black component that connects to the distal transparent component overheating and melting, which could potentially cause burns. Cook Medical clarified that it has received no reports of any overheating along the transparent component of the catheter which comes into contact with the patients’ urethra, bladder and ureter. The recall affects Bu...
Source: Mass Device - April 12, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Catheters Recalls Urology Cook Medical Source Type: news

From Interventional Radiologist to Medtech CEO: Interview with Dr. Bob Smouse, Founder of BrightWater Medical
Welcome to the Medsider interview series, a regular feature at MassDevice. All interviews are conducted by Scott Nelson, Founder of Medsider and Group Director for WCG. We hope you enjoy them! Dr. Bob Smouse has over 20 years of experience in interventional radiology, endovascular surgery and clinical research. In addition to acting as CEO and CMO of BrightWater Medical and teaching at the University of Illinois College of Medicine, he provides interventional medical services to local hospitals through Central Illinois Radiology Associates. Dr. Smouse is a medical consultant and scientific advisory board mem...
Source: Mass Device - February 10, 2017 Category: Medical Equipment Authors: Danielle Kirsh Tags: Blog medsider Smouse Source Type: news

DeviceTalks Q & A: Verb Surgical CEO Scott Huennekens
Few CEOs have been given the mandate Scott Huennekens was charged with as employee No. 1 at Verb Surgical, the robotics spinout backed by Google (NSDQ:GOOG) and Johnson & Johnson (NYSE:JNJ): Go forth and change the world. “Don’t worry about capital, don’t worry about funding,” Huennekens told MassDevice.com publisher Brian Johnson recently. “Just go out and change the world.” Many CEOs might find that daunting. Then again, most CEOs don’t have a $400 million war chest and the backing of 2 of the world’s most innovative companies. And, as...
Source: Mass Device - December 21, 2016 Category: Medical Equipment Authors: MassDevice Tags: DeviceTalks Q&A Robot-Assisted Surgery Wall Street Beat Alphabet Google Inc. Johnson & Johnson Medtronic Verb Surgical Volcano Corp. Source Type: news

Convertible Stent for Ureteral Obstruction Clears FDA Convertible Stent for Ureteral Obstruction Clears FDA
The ConvertX nephroureteral stent system converts from a catheter to a stent in a short office procedure, eliminating the need for a second interventional procedure.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 5, 2016 Category: Consumer Health News Tags: Urology News Alert Source Type: news

MassDevice.com +5 | The top 5 medtech stories for December 5, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. FDA clears BrightWater Medical’s ConvertX nephroureteral stent Ureteral medical device company BrightWater Medical said today it won FDA 510(k) clearance for its ConvertX nephroureteral stent system designed for treating ...
Source: Mass Device - December 5, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

FDA clears BrightWater Medical ’ s ConvertX nephroureteral stent
Ureteral medical device company BrightWater Medical said today it won FDA 510(k) clearance for its ConvertX nephroureteral stent system designed for treating ureteral obstructions. The ConvertX System is designed as a single device intended to replace a series of devices and procedures used to treat severe obstructions of the ureter. Traditional interventions require an implanted nephrostomy catheter to externally drain urine and a second procedure to implant a nephroureteral stent to circumvent blockage. Mountain View, Calif.-based BrightWater’s system is designed to be implanted once and convert from a ne...
Source: Mass Device - December 2, 2016 Category: Medical Equipment Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Regulatory/Compliance Urology BrightWater Medical Source Type: news

Dx: Prostatic Mass
Upon seeing the images on the screen, you notice a tinge of red in your resident’s cheeks as she begins her spiel about the need to perform a prostate exam as part of the work up today. She eloquently explains to the patient that the ultrasound results and his symptoms are concerning for a prostatic mass that is eroding into the base of his urinary bladder (Image 3). On the transverse view of the bladder a hyperechoic mass can be seen along the posterior wall of the bladder. In the longitudinal view, you can see the hypoechoic lumen of the mass originating from the prostate to the lower left of the bladder wall. Your...
Source: EPMonthly.com - December 2, 2016 Category: Emergency Medicine Authors: Logan Plaster Tags: Uncategorized Source Type: news

Meta-Analysis: Alpha Blockers Associated with Passage of Ureteral Stones (FREE)
By Kelly Young Edited by Andr é Sofair, MD, MPH, and William E. Chavey, MD, MS Alpha blockers are associated with high rates of ureteral stone passage, a meta-analysis in The BMJ finds.Researchers analyzed … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - December 1, 2016 Category: Primary Care Source Type: news

Sodium Fluorescein, 10% Dextrose Show Ureteral Patency Best Sodium Fluorescein, 10% Dextrose Show Ureteral Patency Best
Both solutions showed urine jets more clearly than saline or oral phenazopyridine with no increase in operative time or morbidity, data from a randomized trial show.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 9, 2016 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Your NEJM Group Today: Scaling Patient Engagement Initiatives, Tamsulosin for Ureteral Stones, Ohio FM/IM Opportunities (FREE)
By the Editors NEJM Group offers so many valuable resources for practicing clinicians. Here's what we chose for you today:NEJM Catalyst: When … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 19, 2016 Category: Primary Care Source Type: news

Medical Expulsive Therapy Might Benefit Patients With Larger Ureteral Stones, Group Says Medical Expulsive Therapy Might Benefit Patients With Larger Ureteral Stones, Group Says
Medical expulsive therapy (MET) with alpha-blockers might enhance the passage of distal ureteral stones larger than 5 mm, according to a position statement from the European Association of Urology.Reuters Health Information (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - September 6, 2016 Category: Urology & Nephrology Tags: Nephrology News Source Type: news

Texas Medical Centers adds 11 medtech startups to incubator
The Texas Medical Center Innovation Institute on Wednesday announced the addition of 11 startups specifically focused on medical devices, a 1st for the incubator, as part of its TMCx program. As part of the program, for 15 weeks the startups will engage and collaborate with “top industry experts” to move their medical devices from concept to commercialization, the group said. Startup companies will also meet with stakeholders at the 56 member institutions within the Texas Medical Center. “Very few accelerators have a robust program devoted to medical device startups, so we are filling a huge gap in the li...
Source: Mass Device - August 12, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Research & Development Texas Medical Center Innovation Institute Source Type: news

Boston Scientific updates warnings for pelvic mesh products
Boston Scientific (NYSE:BSX) recently updated the directions for use and warnings for its pelvic mesh products, classifying the meshes as permanent implants and warning of complications related to removals. The Marlborough, Mass.-based company added new precautions to the directions for the meshes, warning that that “regardless of the route of delivery,” the meshes have been associated with “erosion” which may require surgical removal. “Complete removal of mesh may not be possible and additional surgeries may not always fully correct the complications,” the company wrote in its...
Source: Mass Device - June 14, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Surgical Urology Women's Health Boston Scientific Source Type: news

BrightWater raises $5.2m in Series A to support ConvertX nephroureteral stent
Ureteral medical device company BrightWater Medical said today it closed a $5.2 million Series A round of financing to support its ConvertX Nephroureteral stent system designed for treating severe ureteral obstructions from development to regulatory filing. The ConvertX System is designed as a single device intended to replace a series of devices and procedures used to treat severe obstructions of the ureter. Traditional interventions require an implanted nephrostomy catheter to externally drain urine and a second procedure to implant a nephroureteral stent to circumvent blockage. BrightWater’s system is designed to ...
Source: Mass Device - May 24, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Urology BrightWater Medical Source Type: news

FDA grants Roche’s cancer immunotherapy Tecentriq (atezolizumab) accelerated approval for people with a specific type of advanced bladder cancer
Roche today announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval to Tecentriq® (atezolizumab) for the treatment of people with locally advanced or metastatic urothelial carcinoma (mUC) who have disease progression during or following platinum-based chemotherapy, or whose disease has worsened within 12 months of receiving platinum-based chemotherapy before surgery (neoadjuvant) or after surgery (adjuvant). Urothelial carcinoma accounts for 90% of all bladder cancers and can also be found in the renal pelvis, ureter and urethra. (Source: Roche Media News)
Source: Roche Media News - May 19, 2016 Category: Pharmaceuticals Source Type: news

More urinary tract stones are being treated with surgery
Researchers who analyzed recent trends related to urinary tract stones in the UK found a sustained and high prevalence of the condition, with an increased trend to treat patients with surgery. The number of upper urinary tract stone episodes in hospitals increased from 83,050 in 2009-2010 to 86,742 in 2014-2015. The use of non-invasive shock wave lithotripsy remained stable over this time; however, surgical intervention for stones in the ureter or kidney rose nearly 50% from 12,062 to 18,055 cases in the 5-year study period. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 12, 2016 Category: Science Source Type: news

New Device Aims to Ease Burden of Treating Ureteral Blockages
(Source: MDDI)
Source: MDDI - April 25, 2016 Category: Medical Equipment Authors: Arundhati Parmar Tags: Stents Source Type: news

Study shows that Wnt secretion preventing drugs may reduce renal fibrosis
For media queries, please contact: Ms Dharshini Subbiah                                                                  Duke-NUS Medical School Email: dharshini.subbiah@duke-nus.edu.sg Mobile: (65) 9616-7532 Renal fibrosis or the scarring of kidneys, following an injury, reduces their function and can cause kidney disease to progressively worsen. In a recent study, published in Kidney International, researchers from Duke-NUS Medical School (Duke-NUS) in Singap...
Source: DukeHealth.org: Duke Health Features - March 30, 2016 Category: Pediatrics Tags: Duke Medicine Source Type: news

Boston Scientific releases ureteral stent tracker app
Boston Scientific (NYSE:BSX) has launched a new app designed to help urologists track ureteral stents implanted in patients with kidney stones. The app was developed as a joint operation between the Marlborough, Mass.-based medical device company and digital healthcare tool developer Visible Health, according to the company’s website. The tracker is designed to address issues with retained ureteral stents by making them more visible to both the care team and the patient themselves, Visible Health said. Boston Scientific said that 13 out of 100 ureteral stents will be forgotten after implantation, and 10 of ...
Source: Mass Device - March 3, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Patient Monitoring Software / IT Urology Boston Scientific Source Type: news

Boston Scientific, app developer launch Ureteral Stent Tracker app
Boston Scientific has launched a new app, called the Ureteral Stent Tracker, that helps urologists and their staff keep tabs on ureteral stents implanted in patients with kidney stones. The app was developed in partnership with health app developer Visible Health. (Source: mobihealthnews)
Source: mobihealthnews - March 2, 2016 Category: Information Technology Source Type: news

Kidney stones are on the rise
This study and past research have not been able to determine the reason kidney stones seem to be on the rise. The rising rate of obesity may be playing a role. Another possibility is climate change, as warmer temperatures encourage dehydration. The fact is, no one knows for sure. What’s a person to do? If you have symptoms of kidney stones, see your doctor or report directly to an emergency room. The most common symptoms are waves of pain in the back or lower abdomen, pain with urination, or blood in the urine. If you’ve already been diagnosed with a kidney stone, it’s important to figure out why it happe...
Source: New Harvard Health Information - February 12, 2016 Category: Consumer Health News Authors: Robert Shmerling, M.D. Tags: Kidney and urinary tract Source Type: news

Finding comfort and hydronephrosis care close to home
AJ Arria was diagnosed and treated at Boston Children’s for hydronephrosis – a urological condition where urine backs up into the kidneys. Every child has a favorite thing. Some find comfort in the softness of a blanket, while others prefer snuggling a stuffed animal. Whatever the soothing item is, every parent cringes at the thought of misplacing it. Michelle Arria remembers the day her 18-month-old son Anthony James (AJ) visited Boston Children’s Hospital for testing. It was the day his favorite blanket was lost. “Testing was about to begin, and I went to get AJ’s blanket, and...
Source: Thrive, Children's Hospital Boston - January 27, 2016 Category: Pediatrics Authors: Maureen McCarthy Tags: Diseases & Conditions Our Patients’ Stories Boston Children's at Peabody Hydronephrosis minimally invasive surgery Richard Yu urology Source Type: news

Boston Scientific launches LithoVue 1-use Ureteroscope
Boston Scientific (NYSE:BSX) said today it launched its LithoVue single-use digital flexible ureteroscope designed for minimally invasive endoscopic procedures such as diagnosing and treating stones and other kidney, ureter and bladder conditions. The single-use scope is designed to be cost-effective compared to multi-use scopes which require maintenance, sterilization and reprocessing, as well as other operational and financial challenges, Boston Scientific said. “Flexible ureteroscopy is considered the gold standard for treating many stones in the ureter and kidney, and the LithoVue System provides h...
Source: Mass Device - January 12, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Imaging Boston Scientific Source Type: news

Boston Scientific Launches LithoVue Single-Use Digital Flexible Ureteroscope In U.S. And Europe
Boston Scientific Corporation has announced the U.S. and European launch of the LithoVueSingle-Use Digital Flexible Ureteroscope for minimally invasive endoscopic procedures to diagnose and treat stones and other conditions of the kidney, ureter and bladder. (Source: Medical Design Online News)
Source: Medical Design Online News - January 12, 2016 Category: Medical Equipment Source Type: news

Jett’s story: A second opinion and a second chance
Allie and Chris Taylor vividly remember the day their second son Jett was born. “Jett was a gift to me — the one I fought and cried for,” Allie recalls. Twenty weeks earlier, during a routine ultrasound conducted at a nearby hospital, Allie and Chris were told their unborn son’s kidneys were enlarged. Doctors feared the worst. “They did a second ultrasound and told us my baby wouldn’t make it past 28 weeks gestation. We were told we should see a specialist but not to keep our hopes high.” Allie and Chris were seen three days later at the Advanced Fetal Care Center at...
Source: Thrive, Children's Hospital Boston - December 15, 2015 Category: Pediatrics Authors: Maureen McCarthy Tags: Diseases & Conditions Our Patients’ Stories Department of Urology Dr. Richard Lee ureterocele vesicoureteral reflux (VUR) Source Type: news

Stryker launches 1588 AIM multimodal surgical video platform
Stryker‘s (NYSE:SYK) endoscopy biz said today it launched the 1588 AIM platform surgical video system designed to allow surgeons to differentiate anatomy during minimally invasive surgical procedures. San Jose, Calif.-based Stryker said the video platform integrates 5 imaging modalities for use in visualizing patient anatomy across laparoscopy, arthroscopy, urology, gynecology, otolaryngology and gastrointestinal surgical specialties. “As surgeons, we need to work hard to provide the best possible outcomes for our patients. This new platform allows us to see critical anatomy in real-time, with a simple tou...
Source: Mass Device - December 14, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Imaging Stryker Source Type: news

Ostomies: Types and Pouching Systems
The terms, 'ostomy,' and, 'stoma,' are general descriptive terms that are often times used interchangeably, although they have different meanings. An, 'ostomy,' refers to the surgically created opening in a person's body for the discharge of body wastes. A, 'stoma,' is the actual end of the ureter or small or large bowel that may be seen protruding through the person's abdominal wall. The most common specific types of ostomies are presented below. (Source: Disabled World)
Source: Disabled World - October 6, 2015 Category: Disability Tags: Editorials Source Type: news

Reducing the risk of vaginal vault prolapse after hysterectomy
The post Reducing the risk of vaginal vault prolapse after hysterectomy appeared first on Hysterectomy Association. When a hysterectomy takes place it is important that the vagina is reattached to what is called the uterosacral-cardinal ligament complex. Despite this, some women may experience what is called a vaginal vault prolapse following their hysterectomy. Vaginal vault prolapse following hysterectomy is more common in women who have had children naturally because their pelvic floor muscles are weaker from the birth process, this is also the reason why women who have given birth naturally are more likely to suffer ot...
Source: The Hysterectomy Association - July 19, 2015 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Hysterectomy Risks vaginal prolapse Source Type: news

My positive hysterectomy experience – Veronica’s story
The post My positive hysterectomy experience – Veronica’s story appeared first on Hysterectomy Association. I have suffered with horrendous menstrual bleeding due to a huge fibroid over the past seven years. I researched fibroid problems and was gladdened by the fact that they shrink during the menopause. As I grew older, heading towards 56 my very heavy periods showed no signs of stopping. The bleeding became heavier as each month went by and my stomach would swell making me look pregnant. In February this year my stomach swelled as usual but my period did not start. Menopause could be starting? The fibroid go...
Source: The Hysterectomy Association - July 13, 2015 Category: OBGYN Authors: Linda Tags: Your Stories fibroids Source Type: news

NCI Is Seeking Mesothelioma Patients for New Clinical Trial
Patients with malignant mesothelioma can participate in an unprecedented clinical trial sponsored by the National Cancer Institute (NCI) that involves matching tumor-related genetic mutations with specific drugs that target the corresponding abnormality. The clinical trial has the potential to change cancer treatment in the future, allowing doctors to prescribe drugs based on the molecular cause of the cancer, not the origin or source of the cancer. It could enhance the potential for treatment success. "It is a unique, groundbreaking trial," said NCI Acting Director Dr. Doug Lowy, when he announced...
Source: Asbestos and Mesothelioma News - July 2, 2015 Category: Environmental Health Authors: Tim Povtak Tags: Treatment & Doctors Source Type: news

Minimally invasive surgery helps Rhode Island boy get back to being a kid
For Jonathan Reed, summer fun goes way beyond wave riding along New England beaches. During a recent weeklong family vacation to Universal Studios in Florida, the Rhode Island fourth-grader visited wave pools at a water park, rode gravity-defying roller coasters and sprinted from one fun-filled attraction to the next. This dream vacation may not have been as magical if Jonathan had to continually battle ongoing stomach pain. For nearly a year and a half, the young lacrosse goalie and avid soccer player battled sporadic and excruciating abdominal pain. These attacks were sharp, swift and appeared to be sparked when on vaca...
Source: Thrive, Children's Hospital Boston - June 25, 2015 Category: Pediatrics Authors: Maureen McCarthy Tags: All posts Our patients’ stories Tests & treatment kidney minimally invasive surgery Ureteropelvic Junction (UPJ) Obstruction Source Type: news

Understanding Stress Incontinence
Stress incontinence is one of the most common forms of incontinence and it’s estimated that three million people in the UK are affected although this number may be conservative because some won’t mention it to their doctors. It also becomes more common in women as they age and go through the menopause. Estimates suggest that 1 in 5 women over 40 may suffer some degree of stress incontinence. As we eat and drink the kidneys produce urine which passes through the ureter tubes to the bladder. The amount we eat and drink influences the amount of urine that is made. As the bladder fills with urine it swells until we...
Source: The Hysterectomy Association - May 23, 2013 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Latest News Videos Women's Health incontinence kegel exercises pelvic floor exercises pelvic floor muscles stress incontinence Source Type: news

Link Between Smoking And Worse Urothelial Cancer Prognosis, Especially For Women
Smoking significantly increases individuals' risk of developing serious forms of urothelial carcinoma and a higher likelihood of dying from the disease, particularly for women. That is the conclusion of a recent study published in BJU International. While the biological mechanisms underlying this gender difference are unknown, the findings indicate that clinicians and society in general should focus on smoking prevention and cessation to safeguard against deadly cancers of the bladder, ureters, and renal pelvis, especially in females... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 18, 2013 Category: Consumer Health News Tags: Urology / Nephrology Source Type: news

Smoking Linked With Worse Urothelial Cancer Prognosis In Patients, Especially Women
Smoking significantly increases individuals' risk of developing serious forms of urothelial carcinoma and a higher likelihood of dying from the disease, particularly for women. That is the conclusion of a recent study published in BJU International. While the biological mechanisms underlying this gender difference are unknown, the findings indicate that clinicians and society in general should focus on smoking prevention and cessation to safeguard against deadly cancers of the bladder, ureters, and renal pelvis, especially in females... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 16, 2013 Category: Consumer Health News Tags: Smoking / Quit Smoking Source Type: news

Smoking linked with worse urothelial cancer prognosis in patients, especially women
(Wiley) Smoking significantly increases individuals' risk of developing serious forms of urothelial carcinoma and a higher likelihood of dying from the disease, particularly for women. That is the conclusion of a recent study published in BJU International. While the biological mechanisms underlying this gender difference are unknown, the findings indicate that clinicians and society in general should focus on smoking prevention and cessation to safeguard against deadly cancers of the bladder, ureters, and renal pelvis, especially in females. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 14, 2013 Category: Global & Universal Source Type: news

Summary: International Kidney Cancer Symposium
Conclusions VHL/PBRM1 mutations confirmed 3rd subtype identified and under review but appears to be mis-classified tumors.  Shows value of molecular methods rather than new mechanistic insights. Integration with survival outcome—suggests molecular detailing can be prognostic Full integrative analysis in process Preliminary data can be found at http://tcga-data.nci.hih.gov/tcga/ FoxO Transcription Factors in mTORC1- Activated Renal Tumorigenesis:  Implications for the RCC Treatment Boyi Gan, MD Anderson Cancer Center FoxO Family Transcription Factors:  mammals possess FoxO...
Source: Kidney Cancer Association - December 15, 2011 Category: Urology & Nephrology Source Type: news

Kidney Cancer Survival Rate Data
By: Neal Kennedy   To calculate the kidney cancer survival rate, you must take several different factors into consideration. Generally speaking, these factors are related to the patient who has been diagnosed with kidney cancer, and the kidney cancer stage.. In gathering their survival rate statistics, researchers take the type of cancer, stage, grade and location into consideration. Factors regarding the patient that must be considered include the individual's age, general health, and ability to undergo necessary treatment. Using data reflecting these factors in recent decades, medical researchers have been able to ...
Source: Kidney Cancer Association - November 23, 2010 Category: Urology & Nephrology Source Type: news